Biotechnology News and Research

RSS

Philanthropists donate $6 million to establish the UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund.

6 Nov 2026

Novel method identifies active tRNAs during cellular protein synthesis

In a new study in Nature Methods, researchers at the Centre for Genomic Regulation (CRG) in Barcelona describe a technique that looks only at the tRNAs on ribosomes busy making proteins.

5 Nov 2026

New AI framework improves early screening for Parkinson's disease

Scientists at Rensselaer Polytechnic Institute (RPI) have developed an artificial intelligence model to streamline and improve screening for Parkinson's disease (PD) so doctors can refer patients for early-stage testing.

5 Nov 2026

Modified zinc finger scaffold suppresses microglial activation in mouse brain

A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease. The approach also reduced the toxicity of protein aggregates that had already formed.

5 Nov 2026

MGI Tech partners with Parque Científico de Madrid to expand access to Stereo-seq in Spain

PCM's new STOmics certification enables cutting-edge spatial transcriptomics, fostering collaboration in genomics and enhancing research capabilities in Spain.

From MGI 4 Nov 2026

African nations seek decision-making power over gene-drive malaria tools

Gene-drive technology, which could stop mosquitoes spreading malaria, is so far confined to laboratories. But as researchers work towards possible field trials in Africa, questions emerge about who will decide how the technology is tested, governed and used.

2 Nov 2026

Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai

Dr. Jue Wang, Head of Global Business Development at Insilico Medicine, has been invited to attend the China Healthcare Summit in Shanghai. On the afternoon of November 3 at 16:45, she will deliver a keynote speech in the panel titled: "THE COMMODITIZATION TRAP: WHO WINS WHEN EVERYONE HAS THE SAME AI?"

30 Oct 2026

New study reveals why colorectal cancer is more aggressive in youth

Dana-Farber Cancer Institute researchers, along with Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, and the Broad Institute, have uncovered biological clues to why colorectal cancer can behave more aggressively in younger people.

29 Oct 2026

Revvity launches Signals LabGistics solution to connect and orchestrate scientific workflows

Revvity, Inc. announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.

From Revvity Signals Software Inc. 29 Oct 2026

New iron contrast agent offers safer cardiac MRI scans

The Biomolecular Nanotechnology research group led by Ikerbasque research professor Aitziber L. Cortajarena from CIC biomaGUNE has developed a new iron-based contrast agent for magnetic resonance imaging that can be used for both diagnosis and treatment.

29 Oct 2026

Insights into enzyme selectivity open new pathways for pharmaceutical synthesis

Enzymes are the molecular tools of life. They accelerate chemical reactions and are able to distinguish very precisely between molecules that are similar to one another. The high selectivity of many enzymes is key to the production of important medicines such as penicillin and cyclosporine. But how did enzymes develop this ability to distinguish between similar chemical functionalities with such precision.

29 Oct 2026

Ancient protein model shows early steps in energy metabolism

Researchers in Japan engineered ancestral nucleoside diphosphate kinase variants with restricted amino acid repertoires to explore alternative catalytic functions. One variant, Arc1-12KR, retained its protein fold despite lacking catalytic histidine and unexpectedly converted two ADP molecules into ATP and AMP. The findings reveal alternative catalytic potential in simplified proteins and offer clues to possible routes of energy metabolism during early protein evolution.

29 Oct 2026

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufacturing.

From Atelerix Ltd 28 Oct 2026